Kami Maddocks

5PUBLICATIONS

20CO-AUTHORS

Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Models of care and place of birthHaematological tumours

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (5)

Sort by Publication Date:

|Jul 10, 2026

Longitudinal plasma neurofilament light chain and patient-reported outcomes as complementary markers of vincristine-associated peripheral neuropathy in adults with lymphoma: a cohort study.

|Feb 04, 2026

Clinical characteristics associated with terminal methotrexate clearance in patients with non-Hodgkin lymphomas receiving high-dose methotrexate.

Zachary J Arnold, Jordan Lundberg, Tracy Wiczer

|Jul 02, 2020

Profile of Polatuzumab Vedotin in the Treatment of Patients with Relapsed/Refractory Non-Hodgkin Lymphoma: A Brief Report on the Emerging Clinical Data.

Yazeed Sawalha, Kami Maddocks

|Nov 10, 2018

Chemotherapy-free induction in MCL: ready for prime time?

Kami Maddocks

|Aug 30, 2018

Update on mantle cell lymphoma.

Kami Maddocks

Pageof 1

Frequent Collaborators

Yazeed Sawalha

David Bond

Timothy J Voorhees

Robert Baiocchi

Beth Christian

Zachary J Arnold

Maryam B Lustberg

Demond Handley

Audrey Sigmund

Walter Hanel

Frequent Collaborators

Yazeed Sawalha

David Bond

Timothy J Voorhees

Robert Baiocchi